Abel Hall LLC
HCAT icon

Abel Hall LLC’s Health Catalyst HCAT Stock Holding History

Abel Hall LLC’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.4K Sell
10,072
-485
-5% -$926 ﹤0.01% 879
2026
Q2 		$21K Buy
+10,557
New +$15.2K ﹤0.01% 942

Other funds holding HCAT

Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Williams & Novak
Williams & Novak Westlake Village, California $169M AUM 17.63% 1-Year Est. Return
Perigon Wealth Management
Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Signal Advisors Wealth
Signal Advisors Wealth Detroit, Michigan $2.27B AUM 16.1% 1-Year Est. Return
Strong Retirement Solutions
Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return
Cigna Investments
Cigna Investments Bloomfield, Connecticut $770M AUM 34.25% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
North Star Investment Management
North Star Investment Management Chicago, Illinois $1.85B AUM 21.53% 1-Year Est. Return

Abel Hall LLC's HCAT Position: Q3 2026 in Review

Abel Hall LLC reduced its Health Catalyst (HCAT) stake by 4.6% in Q3 2026, selling an estimated $926 and leaving 10,072 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Abel Hall LLC first reported a position in HCAT in Q2 2026 and has held it in 2 quarters since. The position peaked at $21K in Q2 2026. 16 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Abel Hall LLC held 10,072 shares of Health Catalyst worth $17.4K as of Q3 2026.
  • Abel Hall LLC sold 485 Health Catalyst shares in Q3 2026, an estimated $926.
  • Health Catalyst made up ﹤0.01% of Abel Hall LLC's portfolio in Q3 2026, its #879 holding.
  • Abel Hall LLC first reported a position in Health Catalyst in Q2 2026 and has held it in 2 quarters since.
  • Abel Hall LLC's Health Catalyst position peaked at $21K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.